CD91 antagonists (Antigenics)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameCD91 antagonists (Antigenics)
Drug Alias NameHSP-96 receptor antagonists (Antigenics)gp96 receptor antagonists (Antigenics)alpha2 macroglobulin antagonists (Antigenics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLow density lipoprotein receptor-related protein-1 inhibitors
TargetsLow density lipoprotein receptor-related protein-1
Therapy Area/IndicationsAutoimmune DiseasesDiabetes Mellitus, Type 1Lupus Erythematosus, Systemic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAgenus Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAgenus Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesDiabetes Mellitus, Type 1Lupus Erythematosus, Systemic +[4] 

Other Information

ATC CodeN/A
Related LinksN/A